Clinical Trial Update: Efficacy and Safety Clinical Trial of Intranasal AST-726 for the Prevention of Migraine [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating intranasal AST-726 for the prevention of migraine, assessing efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine
• Migraine Without Aura
• Migraine with Aura

Drugs mentioned

• AST-726 (AST-726)

Snippet

Sponsor: Ariston Pharmaceuticals, Inc. | Conditions: Migraine, Migraine Headache | Phase 2 | Status: UNKNOWN